Search Results - "Di Nicola, Massimo A."

A phase II study of tinostamustine in patients (pts) with advanced solid tumours by Tinker, Anna, Strauss, James Fredric, Schneider, Reva, Chugh, Rashmi, Curigliano, Giuseppe, Di Nicola, Massimo A., Oaknin, Ana, Janik, Tomas, Hilgier, Kasia, Manamley, Nick, Kummar, Shivaani

“…3021 Background: The novel multi-action alkylating deacetylase inhibitor tinostamustine improves drug access to DNA strands within cancer cells, breaks them…”
Get full text

Two-year follow-up of bintrafusp alfa, a bifunctional fusion protein targeting TGF-β and PD-L1, for second-line (2L) treatment of non-small cell lung cancer (NSCLC) by Cho, Byoung Chul, Kim, Tae Min, Vicente, David, Felip, Enriqueta, Lee, Dae Ho, Lee, Ki Hyeong, Lin, Chia-Chi, Flor, Maria José, Di Nicola, Massimo A., Alvarez, Rosa Maria, Dussault, Isabelle, Helwig, Christoph, Ojalvo, Laureen S., Gulley, James L., Paz-Ares, Luis G.

“…Abstract only 9558 Background: Bintrafusp alfa (M7824) is a first-in-class bifunctional fusion protein composed of the extracellular domain of the TGF-βRII…”
Get full text

Selective modulation of immune transcripts in extracellular vesicles from plasma of renal cell carcinoma patients receiving nivolumab by Verzoni, Elena, Shahaj, Eriomina, Frigerio, Simona, Cova, Agata, Squarcina, Paola, Pesce, Samantha, Vergani, Elisabetta, Vallacchi, Viviana, Lalli, Luca, Pietrantonio, Filippo, Di Nicola, Massimo A., Procopio, Giuseppe, De Braud, Filippo G., Mennitto, Alessia, Claps, Melanie, Sepe, Pierangela, Rodolfo, Monica, Rivoltini, Licia, Huber, Veronica

“…Abstract only 719 Background: Patients (pts) displaying a full-fledged immune response show high levels of circulating extracellular vesicles (EVs) containing…”
Get full text

Role of PD-L1 expression in triple-negative breast cancer stem cells by Di Nicola, Massimo A., Castagnoli, Lorenzo, Cancila, Valeria, Romero, Sandra, Faraci, Simona, Chiodoni, Claudia, Talarico, Giovanna, Fucà, Giovanni, Volpari, Tatiana, Colombo, Mario Paolo, Iorio, Marilena V, Tagliabue, Elda, Tripodo, Claudio, Sangaletti, Sabina, De Braud, Filippo G., Pupa, Serenella

“…Abstract only…”
Get full text

Results from a second-line (2L) NSCLC cohort treated with M7824 (MSB0011359C), a bifunctional fusion protein targeting TGF-β and PD-L1 by Paz-Ares, Luis G., Kim, Tae Min, Vicente Baz, David, Felip, Enriqueta, Lee, Dae Ho, Lee, Ki Hyeong, Lin, Chia-Chi, Di Nicola, Massimo A., Alvarez Alvarez, Rosa Maria, Dussault, Isabelle, Helwig, Christoph, Ojalvo, Laureen, Gulley, James L., Cho, Byoung Chul

“…Abstract only…”
Get full text

Effect of gender on the outcome of patients receiving nivolumab for metastatic renal cancer: Results from a large study population by Procopio, Giuseppe, Di Cosimo, Serena, De Giorgi, Ugo, Cartenì, Giacomo, Cortesi, Enrico, Caserta, Claudia, Sabbatini, Roberto, Bearz, Alessandra, Buti, Sebastiano, Pignata, Sandro, Berruti, Alfredo, Ruggeri, Enzo, Bengala, Carmelo, Livi, Lorenzo, Fagnani, Daniele, Bonetti, Andrea, Mitterer, Manfred, Ortega, Cinzia, Cognetti, Francesco, Di Nicola, Massimo A.

“…Abstract only e16087 Background: Several studies, the majority on melanoma and lung cancer, have addressed the value of gender with respect to immune check…”
Get full text

Correlation between dysthyroidism and efficacy in patients treated with anti PD-1 or anti PDL-1 agents by Signorelli, Diego, Cona, Maria Silvia, Vitali, Milena, Lo Russo, Giuseppe, Proto, Claudia, Imbimbo, Martina, Zilembo, Nicoletta, Platania, Marco, Del Vecchio, Michele, Seregni, Ettore, Garassino, Marina C, Di Nicola, Massimo A., De Braud, Filippo G.

“…Abstract only 67 Background: Immune checkpoints inhibitors have clearly improved patients’outcomes in different tumors, but definitive predictive biomarkers…”
Get full text

OX40 expression in tumor-associated Tregs as a potential prognostic biomarker and immunotherapeutic target in ovarian cancer by Di Nicola, Massimo A., Zappasodi, Roberta, Burocchi, Alessia, Ruggiero, Giusi, Rossini, Anna, Martinelli, Fabio, Tripodo, Claudio, Magni, Michele, Lorusso, Domenica, De Braud, Filippo G., Raspagliesi, Francesco, Colombo, Mario Paolo

“…Abstract only…”
Get full text

Feasibility and efficacy of high doses of antimetabolites followed by high-dose sequential chemoimmunotherapy (R-HDS) and autologous stem cell transplant (ASCT) in patients (pts) with systemic B-cell lymphoma (BCL) and central nervous system (CNS) involvement: A multicenter phase II trial by Ferreri, Andres J.M., Donadoni, Giovanni, Cabras, Maria Giuseppina, Patti, Caterina, Mian, Michael, Zambello, Renato, Tarella, Corrado, Di Nicola, Massimo A., D'Arco, Alfonso, Bruno Ventre, Marta, Foppoli, Marco, Fanni, Alessandro, Doa, Gianluca, Mulè, Antonio, Caligaris-Cappio, Federico, Ciceri, Fabio

“…Abstract only…”
Get full text